Intellectual Property Landscape of the Human Genome
- 14 October 2005
- journal article
- policy forum
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 310 (5746), 239-240
- https://doi.org/10.1126/science.1120014
Abstract
The impact of gene patents on downstream research and innovation are unknown, in part because of a lack of empirical data on the extent and nature of gene patenting. In this Policy Forum, the authors show that 20% of human gene DNA sequences are patented and that some genes are patented as many as 20 times. Unsurprisingly, genes associated with health and disease are more patented than the genome at large. The intellectual property rights for some genes can become highly fragmented between many owners, which suggests that downstream innovators may face considerable costs to gain access to gene-oriented technologies.Keywords
This publication has 26 references indexed in Scilit:
- A GFP-based reporter system to monitor nonsense-mediated mRNA decayNucleic Acids Research, 2005
- NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteinsNucleic Acids Research, 2004
- Gene patenting and medical research: a view from a pharmaceutical companyNature Reviews Drug Discovery, 2004
- A census of human cancer genesNature Reviews Cancer, 2004
- Genetic sequences: how are they patented?Nature Biotechnology, 2004
- Patent searches for genetic sequences: How to retrieve relevant records from patented sequence databasesNature Biotechnology, 2002
- Incumbency and R&D Incentives: Licensing the Gale of Creative DestructionJournal of Economics & Management Strategy, 2000
- Incumbency And R&D Incentives: Licensing The Gale Of Creative DestructionJournal of Economics & Management Strategy, 2000
- Basic Local Alignment Search ToolJournal of Molecular Biology, 1990
- Basic local alignment search toolJournal of Molecular Biology, 1990